Bioreactors Market By Control Type (Automated (MFCs), and Manual), By Material (Stainless Steel, Glass, and Others), By Scale (In Liters) (5L-20L, 20L-200L, 200L-1500L, and Above 1500L), By Usage (Full-Scale Production, Lab-Scale Production, and Pilot Scale Production), By End-Users (Biopharmaceutical Companies, Research & Development Institutes, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), and Others) and By Region - Trends, Analysis and Forecast till 2034

Bioreactors Market was valued at USD 5.5 Billion in 2024 and is projected to grow at a CAGR of 28.90% to reach USD 55.9 Billion by 2034.

Bioreactors are complex systems. Bioreactors are designed for imitating natural production of biomolecules. Bioreactor system is made up of control unit, vessel, auxiliary components and equipment. In vessel all biochemical reaction and living cells occur. In control units, all parameters which are essential to cells are controlled. Equipment & auxiliary components connect and enable the whole system for functioning. Whole system function as an organism, produce desired product under specific conditions. Depending on size of production bioreactors are divided into three scales. Laboratory scale range from 0.5 to 10 liters, industrial scale range from 500 to 5000 liters. Type of bioreactor depends on which molecule will be produced with it and which cell line & components we use.

Bioreactor system is fitted with accessories like sensors, probes, tubing and stirrers. Bioreactor are the vessels which has been designed and produced for providing effective environment for enzymes or whole cells for transforming biochemical into products. Inactivation of cells or sterilization has been carried out in bioreactor such as in treatment of water. Continuous stirred tank bioreactors, airlift bioreactors, packed bed bioreactors, fluidized bed bioreactors, bubble column bioreactors, etc. Bioreactor includes, rocker, stirred tank, air lift, and fixed bed. Smaller scale bioreactors are the glass systems which can be sterilized in an autoclave, multiple use bioreactors requires cleaning after running of each cell culture. Bioreactors are used in various types of industries like medical, food, cosmetics and pharmaceutical industries. Bioreactor is used for upstream processing. Bioreactors are used in production of vaccines, cell therapies, gene therapies and therapeutics. However, rising pharmaceutical and biotechnology industries and use of bioreactors for production of medical and pharmaceutical compounds has given positive impact on target market growth.

Increase in pharmaceutical and biotechnology industries, rising prevalence of diseases and rate of urbanization is one of the leading factors for the Bioreactor Market growth. Urbanization has given rise in consumption of western food, processed food, frozen packed foods, which are unhealthy and affected the health of human being has given rise in prevalence of disease. Urbanization has affected health condition due to emergence of infectious diseases, pollution related health conditions, inadequate house condition and consumption of poor nutrition food. Due to rapid urbanization there is rise in overcrowded settlements, inadequate housing conditions, and lack of infrastructure for water and sanitation which has caused higher risk of infectious diseases. Inadequate hygiene at fast food stalls, rising consumption of unhealthy fast food has given rise in infectious diseases. For example, Typhoid and Cholera are transmitted through water and food contaminated with human faeces which contains pathogen Urbanization has given rise in emergence and spread of arboviral disease like Zika virus, Chikungunya, Dengue which are highly adapted in urban areas. Highly connected urban areas and dense areas has become major hotspot in outbreak of disease like SARS and COVID-19. Medicinal drugs helps in preventing disease and increase immunity power and thus has become important in prevention and spread of disease. Rising diseases has given rise in research & development activities, for development of new drug. Pharmaceutical industries are rising due to clinical research, academics, pharmaceutical journalism, hospital and community pharmacy, quality control, quality assurance, manufacturing new medicinal product, pharmaceutical ,marketing, etc. Biotech industries are growing due to acquisition by big pharmaceutical companies, promising regulatory environment and strong earnings, etc. Rise in aging population, desire for new advancement in pharmaceuticals, medicines, and genetics has given boost to the biotechnology industries. Most important use of bioreactors is for production of medical and pharmaceutical compounds. They are used for making pharmaceutical products like insulin and antibiotics. Bioreactors are sterile vessels with gassing facilities and temperature controls which are required for starting biochemical reaction. Bioreactors support the applications for production of gene therapies, vaccines, cell therapies and therapeutics. Due to beneficial properties bioreactors are used in pharmaceutical and biotechnology industries. According to data published by United Nations in 2018, about 55% of the world’s population resided in urban areas, and it is projected that this percentage will increase over the forecast period. However, the growth in pharmaceutical & biotechnology industries, rising prevalence of disease, and population in urban areas boosts the demand for Bioreactor Market.

Restrains:

Some bioreactors like large and flat rocker bioreactors do not scale well while single-use bioreactor technologies are higher consumable cost, has to rely on vendors, has difficulty in efficiently producing the product in bulk, limit the number of gamma irradiation facilities. Membrane based bioreactors has disadvantage of membrane fouling. However, some kind of disadvantages may somewhat restrain the target market growth.

The Bioreactor Market is segmented based on control type, material, scale, usage, end-users, and region.

On the basis of Control Type, the Bioreactor Market is segmented into Automated (MFCs), and Manual. On the basis of Material, the target market is segmented into Stainless Steel, Glass, and Others. On the basis of Scale (In Liters), the target market is segmented into 5L-20L, 20L-200L, 200L-1500L, and Above 1500L. On the basis of Usage, the target market is segmented into Full-Scale Production, Lab-Scale Production, and Pilot Scale Production. On the basis of End-users, the target market is segmented into Biopharmaceutical Companies, Research & Development Institutes, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), and Others.

Regional Insights:

On region the Bioreactors Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements. Moreover, rising number of bio-manufacturing facilities, presence of well-established biopharmaceutical companies, presence of major key players and increased production capacity is anticipated to increase demand for Bioreactors in the region.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Bioreactors Market report based on control type, material, scale, usage, end-users, and region:

Bioreactors Market, By Control Type:

• Automated (MFCs)
• Manual

Bioreactors Market, By Material:

• Stainless Steel
• Glass
• Others

Bioreactors Market, By Scale:

• 5L-20L
• 20L-200L
• 200L-1500L
• Above 1500L

Bioreactors Market, By Usage:

• Respiratory disease
• Cardiovascular disease
• Infectious disease
• Oncology
• Diabetes
• Immunological disorder
• Others

Bioreactors Market, By End-Users:

• Biopharmaceutical Companies
• Research & Development Institutes
• Contract Manufacturing Organizations (CMOs)
• Contract Research Organizations (CROs)
• Others

Bioreactors Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the Bioreactors Market includes, Thermo Fisher Scientific, Danaher Corporation, CESCO Bioengineering Co., Merck Group, JBT Corporation, Cellexus Ltd., Sartorius AG, Pall Corporation, IKA Company, Froliabo,  and others.

Recent Development:

• In April 2022, JBT Company has launched the Bioreactor as configurable, scalable platform for cultivated meat product. Newly launched ‘READYGo’ Bioreactor helps in delivering scalable & configurable platform which is optimized for cultivated meat products. Newly launched ‘READYGo’ bioreactor meets the global standards for bioprocessing & ideal for scale up work, and offers customers with flexible & customization tailored to individual with unique process.
• In September 2022, Pall Corporation has launched three new ‘Allegro Connect Systems’. Newly launched system include system to support, Bulk Fill, Virus Filtration and Depth Filtration. ‘Allegro Connect Systems’ helps in delivering the enhanced process & risk control by full automation of unit operations which combine to support production of various therapeutic drugs & vaccines.
• In April 2022, IKA has launched new bioreactor ‘HABITAT’ for laboratories. Newly launched ‘HABITAT’ helps in enabling the reproducible & standardized cultivation of various types of cells. Newly launched ‘HABITAT’ is a bioreactor, fermenter and photo-bioreactor in one which sets new standards with ergonomic and efficient operation.

• JBT Corporation
• Thermo Fisher Scientific
• Danaher Corporation
• CESCO Bioengineering Co.
• Merck Group
• Cellexus Ltd.
• Sartorius AG
• Pall Corporation
• IKA Company
• Froliabo